Zolpidem and restoration of consciousness – fact or fiction? by Venter, André
CORRESPONDENCE
798       October 2015, Vol. 105, No. 10
Zolpidem and restoration of 
consciousness – fact or fiction?
To the Editor: Recently the magical effect of zolpidem in bringing 
people in a vegetative state back to life was proclaimed in the general 
media. Since then physicians, including paediatricians, have been 
flooded by hopeful individuals seeking treatment for a wide variety 
of cerebral pathologies. Looking at three recent publications on this 
topic, all may not be as it was made out to be.
Zolpidem is a short-acting non-benzodiazepine gamma-amino-
butyric acid agonist hypnotic approved for the treatment of insomnia. 
It has been shown to have a paradoxical effect in some patients with 
disorders of consciousness, leading to improvement of arousal and 
cognitive abilities. It has been suggested, and partly proven, that 
zolpidem disinhibits the globus pallidus interna, and in that way 
increases the thalamic excitatory role on the frontal lobes.
After a cerebral insult, patients may stay in a prolonged period of 
unconsciousness. They usually evolve from a comatose state to a vegetative 
state (eyes open but only showing reflex behaviours) to a minimally 
conscious state (MCS). This state is characterised by inconsistent 
reproducible evidence of awareness. If these are present without command 
following, it is classified as MCS–, and with command following as MCS+. 
From a research perspective, emergence from an MCS is characterised 
by recovery of functional communication and/or functional object use.[3]
Several case studies have shown that zolpidem effected impressive 
recoveries in patients with severe brain damage of various causes. However, 
this effect occurs in only 5 - 7% of patients. It is important to realise that 
there is not always significant functional recovery; patients may regain 
the ability to follow simple commands, recognise objects and regain some 
communication, but unfortunately the effect lasts for about 4 hours (the 
half-life is 2.4 hours) and is often followed by increased somnolence.
The only placebo-controlled, double blind, single-dose crossover 
study was published last year.[1] A very complex research design, 
involving a cohort of 84 participants (>18 years of age) with traumatic 
and non-traumatic disorders of consciousness of at least 4 months’ 
duration, found that only 4.8% responded to zolpidem. In this study, all 
responders were male with a median age of 34 years. Responders could 
not be distinguished in advance from non-responders, although those 
who did improve were more likely to have some signs of consciousness 
at baseline. The effect was usually apparent by the first hour after drug 
administration, but was already diminished or absent after one further 
hour. Side-effects were rated as mild and no intervention was required. 
Post-response somnolence was seen in several participants. While 10 mg 
was the dose used in this study, other studies have shown an increased 
effect with 20 mg. In one study a responder had been treated (on a 
three times a day dose) for more than 9 years without habituation.[2] 
The majority of persons who benefitted from zolpidem required other 
medications such as amantadine and lamotrigene to improve function.
Conclusions:
• There are no scientific data to support the use of zolpidem in 
children for restoration of consciousness.
• There is a small chance (±5%) that patients in a vegetative state will 
respond favourably.
• The effect of zolpidem is specific for patients in an MCS (probably 
MCS+) and has not been shown for all neurological conditions.
• Even in those patients who respond, functioning may not be 
completely restored.
• Lifelong treatment appears to be necessary, with multiple doses 
daily. There is no evidence whether it could be addictive or not.
• In patients in a vegetative state or MCS, it may be worthwhile to 
consider one dose of 10 mg zolpidem to establish whether or not 
there is a response.
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